Point of Care Infectious Disease Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis
Point of care infectious disease are defined as the diagnostic services and products that are utilized for the detection and confirmation of infectious disease and disorders in patients that provide the outcomes in a significantly lesser time period and in close quarters to the care provision services to the patient. Point of care activities are performed in relatively quick time which can lead to change in patient management.
MARKET DYNAMICS
The key market drivers for Point of Care Infectious Disease Market Includes, increasing prevalence of infectious diseases globally along with rising demand of point of care systems in developing countries due to poor healthcare infrastructure. Whereas, strict regulatory approval for point of care infectious disease testing may expected to restrain market growth during the forecast period.
MARKET SCOPE
The "Point of Care Infectious Disease Market" is a specialized and in-depth study of the Pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of Point of Care Infectious Disease market with detailed market segmentation by technology offering, clinical applications and end user. The Point of Care Infectious Disease Market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in Point of Care Infectious Disease Market and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The Point of Care Infectious Disease Market is segmented on the basis of technology offering, clinical applications and end user. On the basis of technology offering the market is segmented as, solid phase, lateral flow, agglutination assays and flow through. On the basis of clinical applications the market is segmented as, inflammatory diseases, liver disorders, HIV, respiratory disorders, hospital acquired infections, STDs and others. And on the basis of end user the market is segmented as, hospitals, home care, clinics, diagnostic centers and others.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Point of Care Infectious Disease Market based on various segments. It also provides market size and forecast estimates from year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Point of Care Infectious Disease Market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting Point of Care Infectious Disease Market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Point of Care Infectious Disease Market in these regions.
Have a question?
Mrinal
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Point of Care Infectious Disease Market based on various segments. It also provides market size and forecast estimates from year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Point of Care Infectious Disease Market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting Point of Care Infectious Disease Market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Point of Care Infectious Disease Market in these regions.
MARKET PLAYERS
The report covers key developments in the Point of Care Infectious Disease Markets organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Point of Care Infectious Disease Market are anticipated to have lucrative growth opportunities in the future with the rising demand for, Point of Care Infectious Disease market in the global market. Below mentioned is the list of few companies engaged in the Point of Care Infectious Disease Market.
The report also includes the profiles of key players in Point of Care Infectious Disease Market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered financial information of last 3 years, key development in past five years.
- Danaher
- Abbott
- F. Hoffmann-La Roche Ltd
- BD
- Trinity Biotech Ireland
- AccuBio Tech Co.,Ltd
- Cardinal Health
- Thermo Fisher Scientific
- Meridian Bioscience, Inc
- MedMira Inc
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Point Of Care Infectious Disease Market - By Technology Offering
1.3.2 Point Of Care Infectious Disease Market - By Clinical Applications
1.3.3 Point Of Care Infectious Disease Market - By End User
1.3.4 Point Of Care Infectious Disease Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. POINT OF CARE INFECTIOUS DISEASE MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PORTER'S FIVE FORCES ANALYSIS
4.2.1 Bargaining Power of Buyers
4.2.1 Bargaining Power of Suppliers
4.2.1 Threat of Substitute
4.2.1 Threat of New Entrants
4.2.1 Competitive Rivalry
4.3. EXPERT OPINIONS
5. POINT OF CARE INFECTIOUS DISEASE MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. POINT OF CARE INFECTIOUS DISEASE MARKET - GLOBAL MARKET ANALYSIS
6.1. POINT OF CARE INFECTIOUS DISEASE - GLOBAL MARKET OVERVIEW
6.2. POINT OF CARE INFECTIOUS DISEASE - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. POINT OF CARE INFECTIOUS DISEASE MARKET - REVENUE AND FORECASTS TO 2028 - TECHNOLOGY OFFERING
7.1. OVERVIEW
7.2. TECHNOLOGY OFFERING MARKET FORECASTS AND ANALYSIS
7.3. SOLID PHASE
7.3.1. Overview
7.3.2. Solid Phase Market Forecast and Analysis
7.4. LATERAL FLOW
7.4.1. Overview
7.4.2. Lateral Flow Market Forecast and Analysis
7.5. AGGLUTINATION ASSAYS
7.5.1. Overview
7.5.2. Agglutination Assays Market Forecast and Analysis
7.6. FLOW-THROUGH
7.6.1. Overview
7.6.2. Flow-Through Market Forecast and Analysis
8. POINT OF CARE INFECTIOUS DISEASE MARKET - REVENUE AND FORECASTS TO 2028 - CLINICAL APPLICATIONS
8.1. OVERVIEW
8.2. CLINICAL APPLICATIONS MARKET FORECASTS AND ANALYSIS
8.3. TROPICAL DISEASES
8.3.1. Overview
8.3.2. Tropical Diseases Market Forecast and Analysis
8.4. INFLAMMATORY DISEASES
8.4.1. Overview
8.4.2. Inflammatory Diseases Market Forecast and Analysis
8.5. LIVER DISORDERS
8.5.1. Overview
8.5.2. Liver Disorders Market Forecast and Analysis
8.6. HIV
8.6.1. Overview
8.6.2. HIV Market Forecast and Analysis
8.7. RESPIRATORY DISORDERS
8.7.1. Overview
8.7.2. Respiratory Disorders Market Forecast and Analysis
8.8. HOSPITAL ACQUIRED INFECTIONS
8.8.1. Overview
8.8.2. Hospital acquired infections Market Forecast and Analysis
8.9. STDS
8.9.1. Overview
8.9.2. STDs Market Forecast and Analysis
8.10. OTHERS
8.10.1. Overview
8.10.2. Others Market Forecast and Analysis
9. POINT OF CARE INFECTIOUS DISEASE MARKET - REVENUE AND FORECASTS TO 2028 - END USER
9.1. OVERVIEW
9.2. END USER MARKET FORECASTS AND ANALYSIS
9.3. HOSPITALS
9.3.1. Overview
9.3.2. Hospitals Market Forecast and Analysis
9.4. HOME-CARE
9.4.1. Overview
9.4.2. Home-Care Market Forecast and Analysis
9.5. CLINICS
9.5.1. Overview
9.5.2. Clinics Market Forecast and Analysis
9.6. DIAGNOSTIC CENTERS
9.6.1. Overview
9.6.2. Diagnostic Centers Market Forecast and Analysis
9.7. OTHERS
9.7.1. Overview
9.7.2. Others Market Forecast and Analysis
10. POINT OF CARE INFECTIOUS DISEASE MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Point Of Care Infectious Disease Market Overview
10.1.2 North America Point Of Care Infectious Disease Market Forecasts and Analysis
10.1.3 North America Point Of Care Infectious Disease Market Forecasts and Analysis - By Technology Offering
10.1.4 North America Point Of Care Infectious Disease Market Forecasts and Analysis - By Clinical Applications
10.1.5 North America Point Of Care Infectious Disease Market Forecasts and Analysis - By End User
10.1.6 North America Point Of Care Infectious Disease Market Forecasts and Analysis - By Countries
10.1.6.1 United States Point Of Care Infectious Disease Market
10.1.6.1.1 United States Point Of Care Infectious Disease Market by Technology Offering
10.1.6.1.2 United States Point Of Care Infectious Disease Market by Clinical Applications
10.1.6.1.3 United States Point Of Care Infectious Disease Market by End User
10.1.6.2 Canada Point Of Care Infectious Disease Market
10.1.6.2.1 Canada Point Of Care Infectious Disease Market by Technology Offering
10.1.6.2.2 Canada Point Of Care Infectious Disease Market by Clinical Applications
10.1.6.2.3 Canada Point Of Care Infectious Disease Market by End User
10.1.6.3 Mexico Point Of Care Infectious Disease Market
10.1.6.3.1 Mexico Point Of Care Infectious Disease Market by Technology Offering
10.1.6.3.2 Mexico Point Of Care Infectious Disease Market by Clinical Applications
10.1.6.3.3 Mexico Point Of Care Infectious Disease Market by End User
10.2. EUROPE
10.2.1 Europe Point Of Care Infectious Disease Market Overview
10.2.2 Europe Point Of Care Infectious Disease Market Forecasts and Analysis
10.2.3 Europe Point Of Care Infectious Disease Market Forecasts and Analysis - By Technology Offering
10.2.4 Europe Point Of Care Infectious Disease Market Forecasts and Analysis - By Clinical Applications
10.2.5 Europe Point Of Care Infectious Disease Market Forecasts and Analysis - By End User
10.2.6 Europe Point Of Care Infectious Disease Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Point Of Care Infectious Disease Market
10.2.6.1.1 Germany Point Of Care Infectious Disease Market by Technology Offering
10.2.6.1.2 Germany Point Of Care Infectious Disease Market by Clinical Applications
10.2.6.1.3 Germany Point Of Care Infectious Disease Market by End User
10.2.6.2 France Point Of Care Infectious Disease Market
10.2.6.2.1 France Point Of Care Infectious Disease Market by Technology Offering
10.2.6.2.2 France Point Of Care Infectious Disease Market by Clinical Applications
10.2.6.2.3 France Point Of Care Infectious Disease Market by End User
10.2.6.3 Italy Point Of Care Infectious Disease Market
10.2.6.3.1 Italy Point Of Care Infectious Disease Market by Technology Offering
10.2.6.3.2 Italy Point Of Care Infectious Disease Market by Clinical Applications
10.2.6.3.3 Italy Point Of Care Infectious Disease Market by End User
10.2.6.4 Spain Point Of Care Infectious Disease Market
10.2.6.4.1 Spain Point Of Care Infectious Disease Market by Technology Offering
10.2.6.4.2 Spain Point Of Care Infectious Disease Market by Clinical Applications
10.2.6.4.3 Spain Point Of Care Infectious Disease Market by End User
10.2.6.5 United Kingdom Point Of Care Infectious Disease Market
10.2.6.5.1 United Kingdom Point Of Care Infectious Disease Market by Technology Offering
10.2.6.5.2 United Kingdom Point Of Care Infectious Disease Market by Clinical Applications
10.2.6.5.3 United Kingdom Point Of Care Infectious Disease Market by End User
10.2.6.6 Rest of Europe Point Of Care Infectious Disease Market
10.2.6.6.1 Rest of Europe Point Of Care Infectious Disease Market by Technology Offering
10.2.6.6.2 Rest of Europe Point Of Care Infectious Disease Market by Clinical Applications
10.2.6.6.3 Rest of Europe Point Of Care Infectious Disease Market by End User
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Point Of Care Infectious Disease Market Overview
10.3.2 Asia-Pacific Point Of Care Infectious Disease Market Forecasts and Analysis
10.3.3 Asia-Pacific Point Of Care Infectious Disease Market Forecasts and Analysis - By Technology Offering
10.3.4 Asia-Pacific Point Of Care Infectious Disease Market Forecasts and Analysis - By Clinical Applications
10.3.5 Asia-Pacific Point Of Care Infectious Disease Market Forecasts and Analysis - By End User
10.3.6 Asia-Pacific Point Of Care Infectious Disease Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Point Of Care Infectious Disease Market
10.3.6.1.1 Australia Point Of Care Infectious Disease Market by Technology Offering
10.3.6.1.2 Australia Point Of Care Infectious Disease Market by Clinical Applications
10.3.6.1.3 Australia Point Of Care Infectious Disease Market by End User
10.3.6.2 China Point Of Care Infectious Disease Market
10.3.6.2.1 China Point Of Care Infectious Disease Market by Technology Offering
10.3.6.2.2 China Point Of Care Infectious Disease Market by Clinical Applications
10.3.6.2.3 China Point Of Care Infectious Disease Market by End User
10.3.6.3 India Point Of Care Infectious Disease Market
10.3.6.3.1 India Point Of Care Infectious Disease Market by Technology Offering
10.3.6.3.2 India Point Of Care Infectious Disease Market by Clinical Applications
10.3.6.3.3 India Point Of Care Infectious Disease Market by End User
10.3.6.4 Japan Point Of Care Infectious Disease Market
10.3.6.4.1 Japan Point Of Care Infectious Disease Market by Technology Offering
10.3.6.4.2 Japan Point Of Care Infectious Disease Market by Clinical Applications
10.3.6.4.3 Japan Point Of Care Infectious Disease Market by End User
10.3.6.5 South Korea Point Of Care Infectious Disease Market
10.3.6.5.1 South Korea Point Of Care Infectious Disease Market by Technology Offering
10.3.6.5.2 South Korea Point Of Care Infectious Disease Market by Clinical Applications
10.3.6.5.3 South Korea Point Of Care Infectious Disease Market by End User
10.3.6.6 Rest of Asia-Pacific Point Of Care Infectious Disease Market
10.3.6.6.1 Rest of Asia-Pacific Point Of Care Infectious Disease Market by Technology Offering
10.3.6.6.2 Rest of Asia-Pacific Point Of Care Infectious Disease Market by Clinical Applications
10.3.6.6.3 Rest of Asia-Pacific Point Of Care Infectious Disease Market by End User
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Point Of Care Infectious Disease Market Overview
10.4.2 Middle East and Africa Point Of Care Infectious Disease Market Forecasts and Analysis
10.4.3 Middle East and Africa Point Of Care Infectious Disease Market Forecasts and Analysis - By Technology Offering
10.4.4 Middle East and Africa Point Of Care Infectious Disease Market Forecasts and Analysis - By Clinical Applications
10.4.5 Middle East and Africa Point Of Care Infectious Disease Market Forecasts and Analysis - By End User
10.4.6 Middle East and Africa Point Of Care Infectious Disease Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Point Of Care Infectious Disease Market
10.4.6.1.1 South Africa Point Of Care Infectious Disease Market by Technology Offering
10.4.6.1.2 South Africa Point Of Care Infectious Disease Market by Clinical Applications
10.4.6.1.3 South Africa Point Of Care Infectious Disease Market by End User
10.4.6.2 Saudi Arabia Point Of Care Infectious Disease Market
10.4.6.2.1 Saudi Arabia Point Of Care Infectious Disease Market by Technology Offering
10.4.6.2.2 Saudi Arabia Point Of Care Infectious Disease Market by Clinical Applications
10.4.6.2.3 Saudi Arabia Point Of Care Infectious Disease Market by End User
10.4.6.3 U.A.E Point Of Care Infectious Disease Market
10.4.6.3.1 U.A.E Point Of Care Infectious Disease Market by Technology Offering
10.4.6.3.2 U.A.E Point Of Care Infectious Disease Market by Clinical Applications
10.4.6.3.3 U.A.E Point Of Care Infectious Disease Market by End User
10.4.6.4 Rest of Middle East and Africa Point Of Care Infectious Disease Market
10.4.6.4.1 Rest of Middle East and Africa Point Of Care Infectious Disease Market by Technology Offering
10.4.6.4.2 Rest of Middle East and Africa Point Of Care Infectious Disease Market by Clinical Applications
10.4.6.4.3 Rest of Middle East and Africa Point Of Care Infectious Disease Market by End User
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Point Of Care Infectious Disease Market Overview
10.5.2 South and Central America Point Of Care Infectious Disease Market Forecasts and Analysis
10.5.3 South and Central America Point Of Care Infectious Disease Market Forecasts and Analysis - By Technology Offering
10.5.4 South and Central America Point Of Care Infectious Disease Market Forecasts and Analysis - By Clinical Applications
10.5.5 South and Central America Point Of Care Infectious Disease Market Forecasts and Analysis - By End User
10.5.6 South and Central America Point Of Care Infectious Disease Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Point Of Care Infectious Disease Market
10.5.6.1.1 Brazil Point Of Care Infectious Disease Market by Technology Offering
10.5.6.1.2 Brazil Point Of Care Infectious Disease Market by Clinical Applications
10.5.6.1.3 Brazil Point Of Care Infectious Disease Market by End User
10.5.6.2 Argentina Point Of Care Infectious Disease Market
10.5.6.2.1 Argentina Point Of Care Infectious Disease Market by Technology Offering
10.5.6.2.2 Argentina Point Of Care Infectious Disease Market by Clinical Applications
10.5.6.2.3 Argentina Point Of Care Infectious Disease Market by End User
10.5.6.3 Rest of South and Central America Point Of Care Infectious Disease Market
10.5.6.3.1 Rest of South and Central America Point Of Care Infectious Disease Market by Technology Offering
10.5.6.3.2 Rest of South and Central America Point Of Care Infectious Disease Market by Clinical Applications
10.5.6.3.3 Rest of South and Central America Point Of Care Infectious Disease Market by End User
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. POINT OF CARE INFECTIOUS DISEASE MARKET, KEY COMPANY PROFILES
12.1. DANAHER
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. ABBOTT
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. F. HOFFMANN-LA ROCHE LTD
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. BD
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. TRINITY BIOTECH IRELAND
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. ACCUBIOTECH CO., LTD.
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. CARDINAL HEALTH
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. THERMO FISHER SCIENTIFIC
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. MERIDIAN BIOSCIENCE, INC
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. MEDMIRA INC
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
1. Danaher
2. Abbott
3. F. Hoffmann-La Roche Ltd
4. BD
5. Trinity Biotech Ireland
6. AccuBioTech Co., Ltd.
7. Cardinal Health
8. Thermo Fisher Scientific
9. Meridian Bioscience, Inc
10. MedMira Inc
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For